Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
33
NMPA:33
Drug Approvals
Bendamustine Hydrochloride for Injection
- Product Name
- 注射用盐酸苯达莫司汀
- Approval Number
- 国药准字H20253886
- Approval Date
- Apr 15, 2025
NMPA
Bortezomib for Injection
- Product Name
- 注射用硼替佐米
- Approval Number
- 国药准字H20234717
- Approval Date
- Dec 29, 2023
NMPA
Mirabegron Sustained-release Tablets
- Product Name
- 米拉贝隆缓释片
- Approval Number
- 国药准字H20234650
- Approval Date
- Dec 13, 2023
NMPA
Cisatracurium Besilate for Injection
- Product Name
- 注射用苯磺顺阿曲库铵
- Approval Number
- 国药准字H20203524
- Approval Date
- Oct 15, 2020
NMPA
Eptazocine Hydrobromide Injection
- Product Name
- 氢溴酸依他佐辛注射液
- Approval Number
- 国药准字H20065171
- Approval Date
- Sep 29, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found